Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa Inhibitor for Acute Myocardial Infarction

被引：1
作者：
Choi, Woong Gil [1 ]
Oh, Se Won [1 ]
Kim, Young Joong [1 ]
Lim, Jong Gu [1 ]
Jo, Yoon Sik [2 ]
机构：
[1] Konkuk Univ, Sch Med, Chungju Hosp, Dept Cardiol, Chungju 380704, South Korea
[2] Konkuk Univ, Sch Med, Chungju Hosp, Dept Neurol, Chungju 380704, South Korea
来源：
KOREAN CIRCULATION JOURNAL | 2011年 / 41卷 / 09期
关键词：
Myocardial infarction; Acute stroke; Platelet glycoprotein GP IIb-IIIa complex; ISCHEMIC-STROKE; SHORT-TERM; DISEASE;
D O I：
10.4070/kcj.2011.41.9.546
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Stroke is a rare but serious complication of acute myocardial infarction (AMI). Currently, glycoprotein (GP) IIb/IIIa inhibitor is used in clinical practice for acute coronary syndromes and percutaneous coronary interventions (PCIs). The incidence of stroke in patients receiving GP IIb/IIIa inhibitor during PCIs is very low. We report the case of a 47-year-old man who presented with AMI and suffered an acute cerebral infarction after infusion of a GP IIb/IIIa inhibitor following primary PCI.
引用
收藏
页码：546 / 548
页数：3
相关论文
共 9 条
  • [1] Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention
    Akkerhuis, KM
    Deckers, JW
    Lincoff, AM
    Tcheng, JE
    Boersma, E
    Anderson, K
    Balog, C
    Califf, RM
    Topol, EJ
    Simoons, ML
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 78 - 82
  • [2] CEREBROVASCULAR ACCIDENT COMPLICATING ACUTE MYOCARDIAL-INFARCTION - INCIDENCE, CLINICAL-SIGNIFICANCE, AND SHORT-TERM AND LONG-TERM MORTALITY-RATES
    BEHAR, S
    TANNE, D
    ABINADER, E
    AGMON, J
    BARZILAI, J
    FRIEDMAN, Y
    KAPLINSKY, E
    KAULI, N
    KISHON, Y
    PALANT, A
    PELED, B
    REISIN, L
    SCHLESINGER, Z
    ZAHAVI, I
    ZION, M
    GOLDBOURT, U
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) : 45 - 50
  • [3] 오유정, 2009, Korean Circulation Journal, V39, P75
  • [4] An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction
    Chang, GYN
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (03) : 267 - 268
  • [5] NOVEL ANTIPLATELET THERAPIES FOR TREATMENT OF PATIENTS WITH ISCHEMIC-HEART-DISEASE - INHIBITORS OF THE PLATELET GLYCOPROTEIN IIB/IIIA INTEGRIN RECEPTOR
    FRISHMAN, WH
    BURNS, B
    ATAC, B
    ALTURK, N
    ALTAJAR, B
    LERRICK, K
    [J]. AMERICAN HEART JOURNAL, 1995, 130 (04) : 877 - 892
  • [6] CORONARY-ARTERY DISEASE, MYOCARDIAL-INFARCTION, AND BRAIN EMBOLISM
    HESS, DC
    DCRUZ, IA
    ADAMS, RJ
    NICHOLS, FT
    [J]. NEUROLOGIC CLINICS, 1993, 11 (02) : 399 - 417
  • [7] MYOCARDIAL-INFARCTION AND STROKE
    KOMRAD, MS
    COFFEY, CE
    COFFEY, KS
    MCKINNIS, R
    MASSEY, EW
    CALIFF, RM
    [J]. NEUROLOGY, 1984, 34 (11) : 1403 - 1409
  • [8] Ischemic stroke - Impact of a recent myocardial infarction
    Mooe, T
    Olofsson, BO
    Stegmayr, B
    Eriksson, P
    [J]. STROKE, 1999, 30 (05) : 997 - 1001
  • [9] Effect of Intravenous Tirofiban and Aspirin in Reducing Short-Term and Long-Term Neurologic Deficit in Patients with Ischemic Stroke: A Double-Blind Randomized Trial
    Torgano, G.
    Zecca, B.
    Monzani, V.
    Maestroni, A.
    Rossi, P.
    Cazzaniga, M.
    Manganaro, D.
    Boiti, C.
    Zilioli, E.
    Borutti, G.
    Falaschi, F.
    Mandelli, C.
    [J]. CEREBROVASCULAR DISEASES, 2010, 29 (03) : 275 - 281
1